Concepedia
Statistics
Publications
3
Citations
105
H-Index
Active since
2015
Affiliations
Novartis (Switzerland)(Current)
Novartis (United Kingdom)
Costello Medical Consulting (United Kingdom)
Matthew Griffiths is an author at Novartis (Switzerland) specializing in pharmacy, pharmacotherapy, and cost-effectiveness analysis.
Publications per year
2015–2016
Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria
Doreen McBride, Donald E. Stull, Anna Halliday et al. · PharmacoEconomics · 2016 · 40 citations · Full text
Pharmacy, Pharmacoeconomics, Pharmacotherapy +10
Police Mental Health Partnership project: Police Ambulance Crisis Emergency Response (PACER) model development
David Huppert, Matthew Griffiths · Australasian Psychiatry · 2015 · 36 citations
Medicine, Psychiatry, Crisis Intervention +11
Cost-utility of fingolimod compared with dimethyl fumarate in highly active relapsing-remitting multiple sclerosis (RRMS) in England
M. Maruszczak, Stephen Montgomery, Matthew Griffiths et al. · Journal of Medical Economics · 2015 · 29 citations
Pharmacy, Pharmacoeconomics, Pharmacotherapy +17
1–3 of 3